FDA Investigator Art O Czabaniuk

Art O Czabaniuk has conducted inspections on 45 sites in 1 countries as of 18 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
45
Last Inspection Date:
18 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
100002048
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Art O Czabaniuk:
Abdul K Kamara, Adam J Wilson, Alan M Barker, Alanna L Mussawwir Bias, Alexandra A Carrico, Amy S Graf, Andrea F White, Anh M Lac, Anita Narula, PhD, Ann Raju Daniel, Anthony E Keller, RPh, Anthony F Lorenzo, Anthony R Petriella, Armando Morales, Aurora Miha Trifanov, Azza Talaat, Barbara A Rusin, Bei Y He, Benjamin J Smith, Bernard P Heidt, Brent M Dehaan, Brian P Hendrickson, Brian P Putz, Brittany A Mckenzie, Carmen M Faraianu, Caroline H Le, Carolyn J Oyster, Catherine V Quinlan, Cathie S Marshall, Charles M Spyr, Chelsea J Falkowski, Cheng H Yen, Cheryl A Clausen, Cheryl M Monroe, Christian D Lynch (CDL), Christine J Watts, Constantin Y Philopoulos, Courtney E Hillier, Crystal M Young Lewis, Cynthia L Aycock, Daniel J Brown, Daniel J Roberts, Daniel W Stoll, Darren S Morgan, David A Paterson, David J Gasparovich, David L Wilson, David P Moorhead, Deanna L Lampley, Deborah M Trout, Dennis E Swartz, Dylan C Grippi, Emest F Bizjak, Emilie E Kahn, Emily J Orban, Eric E Joneson, Gary Durbiel Goldner, George G Calafactor, Hokenson, Jacob A Clark, Jacob G Lutz, Jacqueline Mdiaz Albertini, James E Szelc, James R Evans, Jeannie M Melin, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Kemp, John N Woodall, Joohi Castelvetere, Joseph A Piechocki, Joseph D Cooper, Joseph R Haynes, Joseph R Strelnik, Joseph T Madak, Judith A Jankowski, Kathryn A Cutajar, Kathryn A Guardiola, Kathryn E Ogger, Kathryn G Brown, Keith J Jasukaitis, Kelley L Clark, Kelli L Wilkinson, Kimberly Lewandowski Walker, Kinh Q Mac, Kristina Mezin, Kristina Nastovski, L'oreal D Fowlkes, L'oreal F Walker, Larry K Austin, Laureen F Kononen, Lauren E Burke, Lauren E Sexton, Lauren M Lilly, PhD, LCDR Anastasia M Piliafas Brown, Leslie A Paul, Linda S Jozefiak, Lindsey Brown, PhD, Lisa J Joseph, Lisa J Renick, Lisa M Thursam, Lisa P Oakes, LT Skip A Payne, LTJG Aaron B Otis, Margaret N Klug, Mark E Parmon, Marlon K Turner, Martha Sullivan Myrick, Martin R Vowell, Matthew B Casale, Matthew J Gretkierewicz, Meisha R Sampson, Meisha Waters, Miah I Schneider, Michael Shanks, MS, Michele L Forster, PhD, Michelle L Jones, Mihaly S Ligmond, Mikhail V Ovanesov, PhD, Nancy A Bellamy, Neali H Lucas, Nicholas J Presto, Nicholas L Paulin, Omotunde O Osunsanmi, Owens, Paige E Shelborne, Patrick B Cummings, Patsy J Domingo, Phenicia T Petty, Prabhu P Raju, Rasha Bamieh, Rebecca E Dombrowski, Regina T Brown, Reginald Walker, Renee L Rice, PhD, Robert G Taylor, Robert M Barbosa, Robert P Whisenant, Roger A Hartman, Rohn R Robertson, Rose Ashley, Ryan J Benedict, Salwa K Poole, Sanket N Patel, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Sargum C Sood, Sherri L Clark, Shirshendu K Deb, PhD, Sidney B Priesmeyer, Sneha S Patel, Sonya M Lambkin, Soyinka S Eneng, Stuart W Russell, Susan M Jackson, Thomas A Peter, Tina M Pawlowski, Tina S Roecklein, Tonnie L Carter, Tracey Asinjen Wiersma, Tracey L Siebesma, Tracey L Taylor, Twana R Chandler, Tyra L Vanleer, Vesa Vuniqi, Victoria A Murray, Wenzheng Wendy Zhang, William D Tingley, William G Nelson, William V Millar

Art O Czabaniuk's Documents

Publish Date Document Type Title
June, 2003 FDA 483 Mycol Balm Laboratories, Inc. - Form 483, 2003-06-23
June, 2003 FDA 483 Liquipak Corporation - Form 483, 2003-06-23
September, 2002 FDA 483 Arrow Chemical Products, Inc. - Form 483, 2002-09-24
October, 2005 EIR Pfizer, Inc. - EIR, 2005-10-05
September, 2002 FDA 483 Crandall Associate, Inc. - Form 483, 2002-09-30
December, 2003 FDA 483 Painexx Corporation - Form 483, 2003-12-23
February, 2002 FDA 483 Baxter COMPASS - Form 483, 2002-02-07
September, 2003 FDA 483 Response Applied Laboratories, Inc. - Form 483R, 2003-10-01
March, 2003 EIR ENDO USA, Inc. - EIR, 2003-03-03
September, 2002 FDA 483 Genesis Pharmaceutical, Inc. - Form 483, 2002-09-17
April, 2003 FDA 483 Response Ash Stevens LLC - Form 483R, 2003-04-14
November, 2003 FDA 483 W. R. Grace & Co.-Conn. - Form 483, 2003-11-13
May, 2004 FDA 483 Genesis Pharmaceutical, Inc. - Form 483, 2004-05-07
April, 2003 EIR Ash Stevens LLC - EIR, 2003-04-01
February, 2008 EIR Burnette Foods, Inc - EIR, 2008-02-15
April, 2003 FDA 483 Ash Stevens LLC - Form 483, 2003-04-01
May, 2004 FDA 483 Terumo Cardiovascular Systems Corporation - Form 483, 2004-05-18
June, 2002 FDA 483 Xela Pack, Inc. - Form 483, 2002-06-07
September, 2002 EIR Genesis Pharmaceutical, Inc. - EIR, 2002-09-17
March, 2004 FDA 483 Arrow Chemical Products, Inc. - Form 483, 2004-03-12
September, 2003 EIR Applied Laboratories, Inc. - EIR, 2003-09-30
October, 2005 FDA 483 Pfizer, Inc. - Form 483, 2005-10-05
March, 2002 FDA 483 Ferndale Laboratories, Inc. - Form 483, 2002-03-27
March, 2003 FDA 483 ENDO USA, Inc. - Form 483, 2003-03-03
March, 2011 FDA 483 Vortech Pharmaceuticals, Ltd. - Form 483, 2011-03-25
September, 2003 FDA 483 Applied Laboratories, Inc. - Form 483, 2003-09-30

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more